Global Hospital Injectable Drugs Market Growth (Status and Outlook) 2021-2026

Publisher Name :
Date: 21-Jan-2021
No. of pages: 156

According to this latest study, the 2020 growth of Hospital Injectable Drugs will have significant change from previous year. By the most conservative estimates of global Hospital Injectable Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 37190 million in 2019. Over the next five years the Hospital Injectable Drugs market will register a 4.9% CAGR in terms of revenue, the global market size will reach US$ 45090 million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Hospital Injectable Drugs market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.

- Generic Sterile Injectables

- Sterile Intravenous (IV) Solutions

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.

- Oncology

- Anesthesia

- Anti-Infectives

- Parenteral Nutrition

- Cardiovascular Diseases

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

- Americas

- United States

- Canada

- Mexico

- Brazil

- APAC

- China

- Japan

- Korea

- Southeast Asia

- India

- Australia

- Europe

- Germany

- France

- UK

- Italy

- Russia

- Middle East & Africa

- Egypt

- South Africa

- Israel

- Turkey

- GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

- Hospira (Pfizer Inc.)

- Baxter

- Fresenius Kabi

- Sandoz (Novartis)

- Hikma Pharmaceuticals PLC

- Dr. Reddy's Laboratories Ltd

- Grifols

- Nichi-Iko Group (Sagent)

- Teva Pharmaceutical

- Otsuka

- B.Braun

- JW Life Science

- Auromedics

- Sanofi

- Gland Pharma

- Endo International PLC

- Sichuan Kelun Pharmaceutical

- Cisen Pharmaceutical

- Shijiazhuang No. 4 Pharmaceutical

- Shandong Hualu Pharmaceutical

- CR Double-Crane

Global Hospital Injectable Drugs Market Growth (Status and Outlook) 2021-2026

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Hospital Injectable Drugs Market Size 2016-2026
2.1.2 Hospital Injectable Drugs Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Hospital Injectable Drugs Segment by Type
2.2.1 Generic Sterile Injectables
2.2.2 Generic Sterile Injectables
2.3 Hospital Injectable Drugs Market Size by Type
2.3.1 Global Hospital Injectable Drugs Market Size CAGR by Type
2.3.2 Global Hospital Injectable Drugs Market Size Market Share by Type (2016-2021)
2.4 Hospital Injectable Drugs Segment by Application
2.4.1 Oncology
2.4.2 Anesthesia
2.4.3 Anti-Infectives
2.4.4 Parenteral Nutrition
2.4.5 Cardiovascular Diseases
2.5 Hospital Injectable Drugs Market Size by Application
2.5.1 Global Hospital Injectable Drugs Market Size CAGR by Application
2.5.2 Global Hospital Injectable Drugs Market Size Market Share by Application (2016-2021)

3 Global Hospital Injectable Drugs by Players
3.1 Hospital Injectable Drugs Market Size Market Share by Players
3.1.1 Global Hospital Injectable Drugs Revenue by Players (2019-2021E)
3.1.2 Global Hospital Injectable Drugs Revenue Market Share by Players (2019-2021E)
3.2 Global Hospital Injectable Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Hospital Injectable Drugs by Regions
4.1 Hospital Injectable Drugs Market Size by Regions (2016-2021)
4.2 Americas Hospital Injectable Drugs Market Size Growth (2016-2021)
4.3 APAC Hospital Injectable Drugs Market Size Growth (2016-2021)
4.4 Europe Hospital Injectable Drugs Market Size Growth (2016-2021)
4.5 Middle East & Africa Hospital Injectable Drugs Market Size Growth (2016-2021)

5 Americas
5.1 Americas Hospital Injectable Drugs Market Size by Country (2016-2021)
5.2 Americas Hospital Injectable Drugs Market Size by Type (2016-2021)
5.3 Americas Hospital Injectable Drugs Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Hospital Injectable Drugs Market Size by Region (2016-2021)
6.2 APAC Hospital Injectable Drugs Market Size by Type (2016-2021)
6.3 APAC Hospital Injectable Drugs Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Hospital Injectable Drugs by Country (2016-2021)
7.2 Europe Hospital Injectable Drugs Market Size by Type (2016-2021)
7.3 Europe Hospital Injectable Drugs Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Hospital Injectable Drugs by Region (2016-2021)
8.2 Middle East & Africa Hospital Injectable Drugs Market Size by Type (2016-2021)
8.3 Middle East & Africa Hospital Injectable Drugs Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Hospital Injectable Drugs Market Forecast
10.1 Global Hospital Injectable Drugs Forecast by Regions (2021-2026)
10.1.1 Global Hospital Injectable Drugs Forecast by Regions (2021-2026)
10.1.2 Americas Hospital Injectable Drugs Forecast
10.1.3 APAC Hospital Injectable Drugs Forecast
10.1.4 Europe Hospital Injectable Drugs Forecast
10.1.5 Middle East & Africa Hospital Injectable Drugs Forecast
10.2 Americas Hospital Injectable Drugs Forecast by Countries (2021-2026)
10.2.1 United States Hospital Injectable Drugs Market Forecast
10.2.2 Canada Hospital Injectable Drugs Market Forecast
10.2.3 Mexico Hospital Injectable Drugs Market Forecast
10.2.4 Brazil Hospital Injectable Drugs Market Forecast
10.3 APAC Hospital Injectable Drugs Forecast by Region (2021-2026)
10.3.1 China Hospital Injectable Drugs Market Forecast
10.3.2 Japan Hospital Injectable Drugs Market Forecast
10.3.3 Korea Hospital Injectable Drugs Market Forecast
10.3.4 Southeast Asia Hospital Injectable Drugs Market Forecast
10.3.5 India Hospital Injectable Drugs Market Forecast
10.3.6 Australia Hospital Injectable Drugs Market Forecast
10.4 Europe Hospital Injectable Drugs Forecast by Country (2021-2026)
10.4.1 Germany Hospital Injectable Drugs Market Forecast
10.4.2 France Hospital Injectable Drugs Market Forecast
10.4.3 UK Hospital Injectable Drugs Market Forecast
10.4.4 Italy Hospital Injectable Drugs Market Forecast
10.4.5 Russia Hospital Injectable Drugs Market Forecast
10.5 Middle East & Africa Hospital Injectable Drugs Forecast by Region (2021-2026)
10.5.1 Egypt Hospital Injectable Drugs Market Forecast
10.5.2 South Africa Hospital Injectable Drugs Market Forecast
10.5.3 Israel Hospital Injectable Drugs Market Forecast
10.5.4 Turkey Hospital Injectable Drugs Market Forecast
10.5.5 GCC Countries Hospital Injectable Drugs Market Forecast
10.6 Global Hospital Injectable Drugs Forecast by Type (2021-2026)
10.8 Global Hospital Injectable Drugs Forecast by Application (2021-2026)

11 Key Players Analysis
11.1 Hospira (Pfizer Inc.)
11.1.1 Hospira (Pfizer Inc.) Company Information
11.1.2 Hospira (Pfizer Inc.) Hospital Injectable Drugs Product Offered
11.1.3 Hospira (Pfizer Inc.) Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 Hospira (Pfizer Inc.) Main Business Overview
11.1.5 Hospira (Pfizer Inc.) Latest Developments
11.2 Baxter
11.2.1 Baxter Company Information
11.2.2 Baxter Hospital Injectable Drugs Product Offered
11.2.3 Baxter Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 Baxter Main Business Overview
11.2.5 Baxter Latest Developments
11.3 Fresenius Kabi
11.3.1 Fresenius Kabi Company Information
11.3.2 Fresenius Kabi Hospital Injectable Drugs Product Offered
11.3.3 Fresenius Kabi Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 Fresenius Kabi Main Business Overview
11.3.5 Fresenius Kabi Latest Developments
11.4 Sandoz (Novartis)
11.4.1 Sandoz (Novartis) Company Information
11.4.2 Sandoz (Novartis) Hospital Injectable Drugs Product Offered
11.4.3 Sandoz (Novartis) Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 Sandoz (Novartis) Main Business Overview
11.4.5 Sandoz (Novartis) Latest Developments
11.5 Hikma Pharmaceuticals PLC
11.5.1 Hikma Pharmaceuticals PLC Company Information
11.5.2 Hikma Pharmaceuticals PLC Hospital Injectable Drugs Product Offered
11.5.3 Hikma Pharmaceuticals PLC Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 Hikma Pharmaceuticals PLC Main Business Overview
11.5.5 Hikma Pharmaceuticals PLC Latest Developments
11.6 Dr. Reddy's Laboratories Ltd
11.6.1 Dr. Reddy's Laboratories Ltd Company Information
11.6.2 Dr. Reddy's Laboratories Ltd Hospital Injectable Drugs Product Offered
11.6.3 Dr. Reddy's Laboratories Ltd Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 Dr. Reddy's Laboratories Ltd Main Business Overview
11.6.5 Dr. Reddy's Laboratories Ltd Latest Developments
11.7 Grifols
11.7.1 Grifols Company Information
11.7.2 Grifols Hospital Injectable Drugs Product Offered
11.7.3 Grifols Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.7.4 Grifols Main Business Overview
11.7.5 Grifols Latest Developments
11.8 Nichi-Iko Group (Sagent)
11.8.1 Nichi-Iko Group (Sagent) Company Information
11.8.2 Nichi-Iko Group (Sagent) Hospital Injectable Drugs Product Offered
11.8.3 Nichi-Iko Group (Sagent) Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.8.4 Nichi-Iko Group (Sagent) Main Business Overview
11.8.5 Nichi-Iko Group (Sagent) Latest Developments
11.9 Teva Pharmaceutical
11.9.1 Teva Pharmaceutical Company Information
11.9.2 Teva Pharmaceutical Hospital Injectable Drugs Product Offered
11.9.3 Teva Pharmaceutical Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.9.4 Teva Pharmaceutical Main Business Overview
11.9.5 Teva Pharmaceutical Latest Developments
11.10 Otsuka
11.10.1 Otsuka Company Information
11.10.2 Otsuka Hospital Injectable Drugs Product Offered
11.10.3 Otsuka Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.10.4 Otsuka Main Business Overview
11.10.5 Otsuka Latest Developments
11. B.Braun
11.11.1 B.Braun Company Information
11.11.2 B.Braun Hospital Injectable Drugs Product Offered
11.11.3 B.Braun Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.11.4 B.Braun Main Business Overview
11.11.5 B.Braun Latest Developments
11.12 JW Life Science
11.12.1 JW Life Science Company Information
11.12.2 JW Life Science Hospital Injectable Drugs Product Offered
11.12.3 JW Life Science Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.12.4 JW Life Science Main Business Overview
11.12.5 JW Life Science Latest Developments
11.13 Auromedics
11.13.1 Auromedics Company Information
11.13.2 Auromedics Hospital Injectable Drugs Product Offered
11.13.3 Auromedics Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.13.4 Auromedics Main Business Overview
11.13.5 Auromedics Latest Developments
11.14 Sanofi
11.14.1 Sanofi Company Information
11.14.2 Sanofi Hospital Injectable Drugs Product Offered
11.14.3 Sanofi Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.14.4 Sanofi Main Business Overview
11.14.5 Sanofi Latest Developments
11.15 Gland Pharma
11.15.1 Gland Pharma Company Information
11.15.2 Gland Pharma Hospital Injectable Drugs Product Offered
11.15.3 Gland Pharma Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.15.4 Gland Pharma Main Business Overview
11.15.5 Gland Pharma Latest Developments
11.16 Endo International PLC
11.16.1 Endo International PLC Company Information
11.16.2 Endo International PLC Hospital Injectable Drugs Product Offered
11.16.3 Endo International PLC Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.16.4 Endo International PLC Main Business Overview
11.16.5 Endo International PLC Latest Developments
11.17 Sichuan Kelun Pharmaceutical
11.17.1 Sichuan Kelun Pharmaceutical Company Information
11.17.2 Sichuan Kelun Pharmaceutical Hospital Injectable Drugs Product Offered
11.17.3 Sichuan Kelun Pharmaceutical Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.17.4 Sichuan Kelun Pharmaceutical Main Business Overview
11.17.5 Sichuan Kelun Pharmaceutical Latest Developments
11.18 Cisen Pharmaceutical
11.18.1 Cisen Pharmaceutical Company Information
11.18.2 Cisen Pharmaceutical Hospital Injectable Drugs Product Offered
11.18.3 Cisen Pharmaceutical Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.18.4 Cisen Pharmaceutical Main Business Overview
11.18.5 Cisen Pharmaceutical Latest Developments
11.19 Shijiazhuang No. 4 Pharmaceutical
11.19.1 Shijiazhuang No. 4 Pharmaceutical Company Information
11.19.2 Shijiazhuang No. 4 Pharmaceutical Hospital Injectable Drugs Product Offered
11.19.3 Shijiazhuang No. 4 Pharmaceutical Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.19.4 Shijiazhuang No. 4 Pharmaceutical Main Business Overview
11.19.5 Shijiazhuang No. 4 Pharmaceutical Latest Developments
11.20 Shandong Hualu Pharmaceutical
11.20.1 Shandong Hualu Pharmaceutical Company Information
11.20.2 Shandong Hualu Pharmaceutical Hospital Injectable Drugs Product Offered
11.20.3 Shandong Hualu Pharmaceutical Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.20.4 Shandong Hualu Pharmaceutical Main Business Overview
11.20.5 Shandong Hualu Pharmaceutical Latest Developments
11.21 CR Double-Crane
11.21.1 CR Double-Crane Company Information
11.21.2 CR Double-Crane Hospital Injectable Drugs Product Offered
11.21.3 CR Double-Crane Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.21.4 CR Double-Crane Main Business Overview
11.21.5 CR Double-Crane Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Hospital Injectable Drugs Market Size CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Generic Sterile Injectables
Table 3. Major Players of Sterile Intravenous (IV) Solutions
Table 4. Hospital Injectable Drugs Market Size CAGR by Type (2016-2021) & ($ Millions)
Table 5. Global Hospital Injectable Drugs Market Size by Type (2016-2021) & ($ Millions)
Table 6. Global Hospital Injectable Drugs Market Size Market Share by Type (2016-2021)
Table 7. Hospital Injectable Drugs Market Size CAGR by Application (2016-2021) & ($ Millions)
Table 8. Global Hospital Injectable Drugs Market Size by Application (2016-2021) & ($ Millions)
Table 9. Global Hospital Injectable Drugs Market Size Market Share by Application (2016-2021)
Table 10. Global Hospital Injectable Drugs Revenue by Players (2019-2021E) & ($ Millions)
Table 11. Global Hospital Injectable Drugs Revenue Market Share by Players (2019-2021E)
Table 12. Global Hospital Injectable Drugs Key Players Head office and Products Offered
Table 13. Hospital Injectable Drugs Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Hospital Injectable Drugs Market Size by Regions 2016-2021 & ($ Millions)
Table 17. Global Hospital Injectable Drugs Market Size Market Share by Regions 2016-2021
Table 18. Americas Hospital Injectable Drugs Market Size by Country (2016-2021) & ($ Millions)
Table 19. Americas Hospital Injectable Drugs Market Size Market Share by Country (2016-2021)
Table 20. Americas Hospital Injectable Drugs Market Size by Type (2016-2021) & ($ Millions)
Table 21. Americas Hospital Injectable Drugs Market Size Market Share by Type (2016-2021)
Table 22. Americas Hospital Injectable Drugs Market Size by Application (2016-2021) & ($ Millions)
Table 23. Americas Hospital Injectable Drugs Market Size Market Share by Application (2016-2021)
Table 24. APAC Hospital Injectable Drugs Market Size by Region (2016-2021) & ($ Millions)
Table 25. APAC Hospital Injectable Drugs Market Size Market Share by Region (2016-2021)
Table 26. APAC Hospital Injectable Drugs Market Size by Type (2016-2021) & ($ Millions)
Table 27. APAC Hospital Injectable Drugs Market Size Market Share by Type (2016-2021)
Table 28. APAC Hospital Injectable Drugs Market Size by Application (2016-2021) & ($ Millions)
Table 29. APAC Hospital Injectable Drugs Market Size Market Share by Application (2016-2021)
Table 30. Europe Hospital Injectable Drugs Market Size by Country (2016-2021) & ($ Millions)
Table 31. Europe Hospital Injectable Drugs Market Size Market Share by Country (2016-2021)
Table 32. Europe Hospital Injectable Drugs Market Size by Type (2016-2021) & ($ Millions)
Table 33. Europe Hospital Injectable Drugs Market Size Market Share by Type (2016-2021)
Table 34. Europe Hospital Injectable Drugs Market Size by Application (2016-2021) & ($ Millions)
Table 35. Europe Hospital Injectable Drugs Market Size Market Share by Application (2016-2021)
Table 36. Middle East & Africa Hospital Injectable Drugs Market Size by Region (2016-2021) & ($ Millions)
Table 37. Middle East & Africa Hospital Injectable Drugs Market Size Market Share by Region (2016-2021)
Table 38. Middle East & Africa Hospital Injectable Drugs Market Size by Type (2016-2021) & ($ Millions)
Table 39. Middle East & Africa Hospital Injectable Drugs Market Size Market Share by Type (2016-2021)
Table 40. Middle East & Africa Hospital Injectable Drugs Market Size by Application (2016-2021) & ($ Millions)
Table 41. Middle East & Africa Hospital Injectable Drugs Market Size Market Share by Application (2016-2021)
Table 42. Key and Potential Regions of Hospital Injectable Drugs
Table 43. Key Application and Potential Industries of Hospital Injectable Drugs
Table 44. Key Challenges of Hospital Injectable Drugs
Table 45. Key Trends of Hospital Injectable Drugs
Table 46. Global Hospital Injectable Drugs Market Size Forecast by Regions (2021-2026) & ($ Millions)
Table 47. Global Hospital Injectable Drugs Market Size Market Share Forecast by Regions
Table 48. Global Hospital Injectable Drugs Market Size Forecast by Type (2021-2026) & ($ Millions)
Table 49. Global Hospital Injectable Drugs Market Size Market Share Forecast by Type (2021-2026)
Table 50. Global Hospital Injectable Drugs Market Size Forecast by Application (2021-2026) & ($ Millions)
Table 51. Global Hospital Injectable Drugs Market Size Market Share Forecast by Application (2021-2026)
Table 52. Hospira (Pfizer Inc.) Details, Company Type, Hospital Injectable Drugs Area Served and Its Competitors
Table 53. Hospira (Pfizer Inc.) Hospital Injectable Drugs Product Offered
Table 54. Hospira (Pfizer Inc.) Hospital Injectable Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 55. Hospira (Pfizer Inc.) Main Business
Table 56. Hospira (Pfizer Inc.) Latest Developments
Table 57. Baxter Details, Company Type, Hospital Injectable Drugs Area Served and Its Competitors
Table 58. Baxter Hospital Injectable Drugs Product Offered
Table 59. Baxter Main Business
Table 60. Baxter Hospital Injectable Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 61. Baxter Latest Developments
Table 62. Fresenius Kabi Details, Company Type, Hospital Injectable Drugs Area Served and Its Competitors
Table 63. Fresenius Kabi Hospital Injectable Drugs Product Offered
Table 64. Fresenius Kabi Main Business
Table 65. Fresenius Kabi Hospital Injectable Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 66. Fresenius Kabi Latest Developments
Table 67. Sandoz (Novartis) Details, Company Type, Hospital Injectable Drugs Area Served and Its Competitors
Table 68. Sandoz (Novartis) Hospital Injectable Drugs Product Offered
Table 69. Sandoz (Novartis) Main Business
Table 70. Sandoz (Novartis) Hospital Injectable Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 71. Sandoz (Novartis) Latest Developments
Table 72. Hikma Pharmaceuticals PLC Details, Company Type, Hospital Injectable Drugs Area Served and Its Competitors
Table 73. Hikma Pharmaceuticals PLC Hospital Injectable Drugs Product Offered
Table 74. Hikma Pharmaceuticals PLC Main Business
Table 75. Hikma Pharmaceuticals PLC Hospital Injectable Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 76. Hikma Pharmaceuticals PLC Latest Developments
Table 77. Dr. Reddy's Laboratories Ltd Details, Company Type, Hospital Injectable Drugs Area Served and Its Competitors
Table 78. Dr. Reddy's Laboratories Ltd Hospital Injectable Drugs Product Offered
Table 79. Dr. Reddy's Laboratories Ltd Main Business
Table 80. Dr. Reddy's Laboratories Ltd Hospital Injectable Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 81. Dr. Reddy's Laboratories Ltd Latest Developments
Table 82. Grifols Details, Company Type, Hospital Injectable Drugs Area Served and Its Competitors
Table 83. Grifols Hospital Injectable Drugs Product Offered
Table 84. Grifols Main Business
Table 85. Grifols Hospital Injectable Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 86. Grifols Latest Developments
Table 87. Nichi-Iko Group (Sagent) Details, Company Type, Hospital Injectable Drugs Area Served and Its Competitors
Table 88. Nichi-Iko Group (Sagent) Hospital Injectable Drugs Product Offered
Table 89. Nichi-Iko Group (Sagent) Main Business
Table 90. Nichi-Iko Group (Sagent) Hospital Injectable Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 91. Nichi-Iko Group (Sagent) Latest Developments
Table 92. Teva Pharmaceutical Details, Company Type, Hospital Injectable Drugs Area Served and Its Competitors
Table 93. Teva Pharmaceutical Hospital Injectable Drugs Product Offered
Table 94. Teva Pharmaceutical Main Business
Table 95. Teva Pharmaceutical Hospital Injectable Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 96. Teva Pharmaceutical Latest Developments
Table 97. Otsuka Details, Company Type, Hospital Injectable Drugs Area Served and Its Competitors
Table 98. Otsuka Hospital Injectable Drugs Product Offered
Table 99. Otsuka Main Business
Table 100. Otsuka Hospital Injectable Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 101. Otsuka Latest Developments
Table 102. B.Braun Details, Company Type, Hospital Injectable Drugs Area Served and Its Competitors
Table 103. B.Braun Hospital Injectable Drugs Product Offered
Table 104. B.Braun Hospital Injectable Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 105. B.Braun Main Business
Table 106. B.Braun Latest Developments
Table 107. JW Life Science Details, Company Type, Hospital Injectable Drugs Area Served and Its Competitors
Table 108. JW Life Science Hospital Injectable Drugs Product Offered
Table 109. JW Life Science Main Business
Table 110. JW Life Science Hospital Injectable Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 111. JW Life Science Latest Developments
Table 112. Auromedics Details, Company Type, Hospital Injectable Drugs Area Served and Its Competitors
Table 113. Auromedics Hospital Injectable Drugs Product Offered
Table 114. Auromedics Main Business
Table 115. Auromedics Hospital Injectable Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 116. Auromedics Latest Developments
Table 117. Sanofi Details, Company Type, Hospital Injectable Drugs Area Served and Its Competitors
Table 118. Sanofi Hospital Injectable Drugs Product Offered
Table 119. Sanofi Main Business
Table 120. Sanofi Hospital Injectable Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 121. Sanofi Latest Developments
Table 122. Gland Pharma Details, Company Type, Hospital Injectable Drugs Area Served and Its Competitors
Table 123. Gland Pharma Hospital Injectable Drugs Product Offered
Table 124. Gland Pharma Main Business
Table 125. Gland Pharma Hospital Injectable Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 126. Gland Pharma Latest Developments
Table 127. Endo International PLC Details, Company Type, Hospital Injectable Drugs Area Served and Its Competitors
Table 128. Endo International PLC Hospital Injectable Drugs Product Offered
Table 129. Endo International PLC Main Business
Table 130. Endo International PLC Hospital Injectable Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 131. Endo International PLC Latest Developments
Table 132. Sichuan Kelun Pharmaceutical Details, Company Type, Hospital Injectable Drugs Area Served and Its Competitors
Table 133. Sichuan Kelun Pharmaceutical Hospital Injectable Drugs Product Offered
Table 134. Sichuan Kelun Pharmaceutical Main Business
Table 135. Sichuan Kelun Pharmaceutical Hospital Injectable Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 136. Sichuan Kelun Pharmaceutical Latest Developments
Table 137. Cisen Pharmaceutical Details, Company Type, Hospital Injectable Drugs Area Served and Its Competitors
Table 138. Cisen Pharmaceutical Hospital Injectable Drugs Product Offered
Table 139. Cisen Pharmaceutical Main Business
Table 140. Cisen Pharmaceutical Hospital Injectable Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 141. Cisen Pharmaceutical Latest Developments
Table 142. Shijiazhuang No. 4 Pharmaceutical Details, Company Type, Hospital Injectable Drugs Area Served and Its Competitors
Table 143. Shijiazhuang No. 4 Pharmaceutical Hospital Injectable Drugs Product Offered
Table 144. Shijiazhuang No. 4 Pharmaceutical Main Business
Table 145. Shijiazhuang No. 4 Pharmaceutical Hospital Injectable Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 146. Shijiazhuang No. 4 Pharmaceutical Latest Developments
Table 147. Shandong Hualu Pharmaceutical Details, Company Type, Hospital Injectable Drugs Area Served and Its Competitors
Table 148. Shandong Hualu Pharmaceutical Hospital Injectable Drugs Product Offered
Table 149. Shandong Hualu Pharmaceutical Main Business
Table 150. Shandong Hualu Pharmaceutical Hospital Injectable Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 151. Shandong Hualu Pharmaceutical Latest Developments
Table 152. CR Double-Crane Details, Company Type, Hospital Injectable Drugs Area Served and Its Competitors
Table 153. CR Double-Crane Hospital Injectable Drugs Product Offered
Table 154. CR Double-Crane Hospital Injectable Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 155. CR Double-Crane Main Business
Table 156. CR Double-Crane Latest Developments

List of Figures

Figure 1. Hospital Injectable Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Hospital Injectable Drugs Market Size Growth Rate 2016-2026 ($ Millions)
Figure 6. Global Hospital Injectable Drugs Market Size Market Share by Type (2016-2021)
Figure 7. Hospital Injectable Drugs in Oncology
Figure 8. Global Hospital Injectable Drugs Market: Oncology (2016-2021) & ($ Millions)
Figure 9. Hospital Injectable Drugs in Anesthesia
Figure 10. Global Hospital Injectable Drugs Market: Anesthesia (2016-2021) & ($ Millions)
Figure 11. Hospital Injectable Drugs in Anti-Infectives
Figure 12. Global Hospital Injectable Drugs Market: Anti-Infectives (2016-2021) & ($ Millions)
Figure 13. Hospital Injectable Drugs in Parenteral Nutrition
Figure 14. Global Hospital Injectable Drugs Market: Parenteral Nutrition (2016-2021) & ($ Millions)
Figure 15. Hospital Injectable Drugs in Cardiovascular Diseases
Figure 16. Global Hospital Injectable Drugs Market: Cardiovascular Diseases (2016-2021) & ($ Millions)
Figure 17. Global Hospital Injectable Drugs Market Size Market Share by Application in 2020
Figure 18. Global Hospital Injectable Drugs Revenue Market Share by Player in 2020
Figure 19. Global Hospital Injectable Drugs Market Size Market Share by Regions (2016-2021)
Figure 20. Americas Hospital Injectable Drugs Market Size 2016-2021 ($ Millions)
Figure 21. APAC Hospital Injectable Drugs Market Size 2016-2021 ($ Millions)
Figure 22. Europe Hospital Injectable Drugs Market Size 2016-2021 ($ Millions)
Figure 23. Middle East & Africa Hospital Injectable Drugs Market Size 2016-2021 ($ Millions)
Figure 24. Americas Hospital Injectable Drugs Market Size Market Share by Country in 2020
Figure 25. Americas Hospital Injectable Drugs Market Size Market Share by Type in 2020
Figure 26. Americas Hospital Injectable Drugs Market Size Market Share by Application in 2020
Figure 27. United States Hospital Injectable Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 28. Canada Hospital Injectable Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 29. Mexico Hospital Injectable Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 30. APAC Hospital Injectable Drugs Market Size Market Share by Regions in 2020
Figure 31. APAC Hospital Injectable Drugs Market Size Market Share by Type in 2020
Figure 32. APAC Hospital Injectable Drugs Market Size Market Share by Application in 2020
Figure 33. China Hospital Injectable Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 34. Japan Hospital Injectable Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 35. Korea Hospital Injectable Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 36. Southeast Asia Hospital Injectable Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 37. India Hospital Injectable Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 38. Australia Hospital Injectable Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 39. Europe Hospital Injectable Drugs Market Size Market Share by Countries in 2020
Figure 40. Europe Hospital Injectable Drugs Market Size Market Share by Type in 2020
Figure 41. Europe Hospital Injectable Drugs Market Size Market Share by Application in 2020
Figure 42. Germany Hospital Injectable Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 43. France Hospital Injectable Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 44. UK Hospital Injectable Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 45. Italy Hospital Injectable Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 46. Russia Hospital Injectable Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 47. Middle East & Africa Hospital Injectable Drugs Market Size Market Share by Region in 2020
Figure 48. Middle East & Africa Hospital Injectable Drugs Market Size Market Share by Type in 2020
Figure 49. Middle East & Africa Hospital Injectable Drugs Market Size Market Share by Application in 2020
Figure 50. Egypt Hospital Injectable Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 51. South Africa Hospital Injectable Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 52. Israel Hospital Injectable Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 53. Turkey Hospital Injectable Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 54. GCC Countries Hospital Injectable Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 55. Americas Hospital Injectable Drugs Market Size 2021-2026 ($ Millions)
Figure 56. APAC Hospital Injectable Drugs Market Size 2021-2026 ($ Millions)
Figure 57. Europe Hospital Injectable Drugs Market Size 2021-2026 ($ Millions)
Figure 58. Middle East & Africa Hospital Injectable Drugs Market Size 2021-2026 ($ Millions)
Figure 59. United States Hospital Injectable Drugs Market Size 2021-2026 ($ Millions)
Figure 60. Canada Hospital Injectable Drugs Market Size 2021-2026 ($ Millions)
Figure 61. Mexico Hospital Injectable Drugs Market Size 2021-2026 ($ Millions)
Figure 62. Brazil Hospital Injectable Drugs Market Size 2021-2026 ($ Millions)
Figure 63. China Hospital Injectable Drugs Market Size 2021-2026 ($ Millions)
Figure 64. Japan Hospital Injectable Drugs Market Size 2021-2026 ($ Millions)
Figure 65. Korea Hospital Injectable Drugs Market Size 2021-2026 ($ Millions)
Figure 66. Southeast Asia Hospital Injectable Drugs Market Size 2021-2026 ($ Millions)
Figure 67. India Hospital Injectable Drugs Market Size 2021-2026 ($ Millions)
Figure 68. Australia Hospital Injectable Drugs Market Size 2021-2026 ($ Millions)
Figure 69. Germany Hospital Injectable Drugs Market Size 2021-2026 ($ Millions)
Figure 70. France Hospital Injectable Drugs Market Size 2021-2026 ($ Millions)
Figure 71. UK Hospital Injectable Drugs Market Size 2021-2026 ($ Millions)
Figure 72. Italy Hospital Injectable Drugs Market Size 2021-2026 ($ Millions)
Figure 73. Russia Hospital Injectable Drugs Market Size 2021-2026 ($ Millions)
Figure 74. Spain Hospital Injectable Drugs Market Size 2021-2026 ($ Millions)
Figure 75. Egypt Hospital Injectable Drugs Market Size 2021-2026 ($ Millions)
Figure 76. South Africa Hospital Injectable Drugs Market Size 2021-2026 ($ Millions)
Figure 77. Israel Hospital Injectable Drugs Market Size 2021-2026 ($ Millions)
Figure 78. Turkey Hospital Injectable Drugs Market Size 2021-2026 ($ Millions)
Figure 79. GCC Countries Hospital Injectable Drugs Market Size 2021-2026 ($ Millions)
  • (Post-pandemic Era) - Global Herbal Oil Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2016-2027
    Published: 26-Feb-2021        Price: US 3650 Onwards        Pages: 118
    Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly opt......
  • Post-pandemic Era - Global Herbal Oil Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
    Published: 26-Feb-2021        Price: US 3620 Onwards        Pages: 112
    Summary World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war. Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing glo......
  • (Post-pandemic Era) - Global Herbal Oil Market Analysis 2021, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
    Published: 26-Feb-2021        Price: US 3160 Onwards        Pages: 97
    Summary At the time of this report, many government announced a plan on reopening the national economy, but many countries are still at the stage of rising. It should be noted that the impact of the epidemic has accelerated the trend of localization, regionalization and decentralization of the global industrial chain and supply chain, so it is inevitable to reconstruct the global industrial chain. Faced with the global industrial change in the post epidemic era, enterprises in var......
  • (Post-pandemic Era) - Global Excipients Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2016-2027
    Published: 26-Feb-2021        Price: US 3650 Onwards        Pages: 105
    Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly opt......
  • Post-pandemic Era - Global Excipients Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
    Published: 26-Feb-2021        Price: US 3620 Onwards        Pages: 105
    Summary World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war. Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing glo......
  • (Post-pandemic Era) - Global Excipients Market Analysis 2021, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
    Published: 26-Feb-2021        Price: US 3160 Onwards        Pages: 81
    Summary At the time of this report, many government announced a plan on reopening the national economy, but many countries are still at the stage of rising. It should be noted that the impact of the epidemic has accelerated the trend of localization, regionalization and decentralization of the global industrial chain and supply chain, so it is inevitable to reconstruct the global industrial chain. Faced with the global industrial change in the post epidemic era, enterprises in var......
  • (Post-pandemic Era) - Global Cold Chain for Pharmaceutical Market Assessment, With Major Companies Analysis, Regional Analysis, Breakdown Data by Application/Type 2021
    Published: 26-Feb-2021        Price: US 4860 Onwards        Pages: 80
    Summary This study analysis was given on a worldwide scale, for instance, present and historical Cold Chain for Pharmaceutical growth analysis, competitive analysis, and also the growth prospects of the major regions. The report gives an exhaustive investigation of this market at country & regional levels, and provides an analysis of the industry trends in each of the sub-segments, from production, revenue and consumption. A quantitative and qualitative analysis of the main player......
  • (Post-pandemic Era) - Global Cold Chain for Pharmaceutical Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2016-2027
    Published: 26-Feb-2021        Price: US 3650 Onwards        Pages: 103
    Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly opt......
  • Post-pandemic Era - Global Cold Chain for Pharmaceutical Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
    Published: 26-Feb-2021        Price: US 3620 Onwards        Pages: 103
    Summary World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war. Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing glo......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs